Mepolizumab For The Treatment Of Patients With Eosinophilic Granulomatosis With Polyangiitis: A Phase Iii Randomized, Placebo-Controlled Trial
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Conference item |
Publicado: |
American Thoracic Society
2017
|